Predictors of increase in chronicity index and of kidney function impairment at repeat biopsy in lupus nephritis.
Cyclophosphamide
Lupus Erythematosus, Systemic
Lupus Nephritis
Journal
Lupus science & medicine
ISSN: 2053-8790
Titre abrégé: Lupus Sci Med
Pays: England
ID NLM: 101633705
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
28
04
2022
accepted:
30
07
2022
entrez:
16
8
2022
pubmed:
17
8
2022
medline:
19
8
2022
Statut:
ppublish
Résumé
Based on available data, the histological predictors of long-term outcome of lupus nephritis (LN) are not clearly defined. Aims of this retrospective study were: (i) to evaluate the change of chronicity index from the first to second kidney biopsy and to find the predictors of chronicity index increase and (ii) to detect the clinical/histological features at first and at second kidney biopsy associated with long-term kidney function impairment. Among 203 biopsy proven LN subjects, 61 repeated kidney biopsy 49 months after the first biopsy. The reasons for repeated biopsy were: nephritic flares in 25 (41%), proteinuric flares in 21 (36%) of patients and protocol biopsy in 14 (23%) of cases. During 23-year follow-up, 25 patients presented a decrease in glomerular filtration rate (eGFR) ≥30%. At repeat biopsy, chronicity index increased in 44 participants (72%) and did not increase in 17 (28%). Nephritic syndrome and serum creatinine >1.6 mg/dL at presentation correlated with chronicity index increase (p=0.031, 0.027, respectively), cyclophosphamide therapy tended to protect against chronicity index increase (p=0.059). Kidney flares occurred in 53.6% of patients with vs 23.5% of those without chronicity index increase (p=0.035). Chronicity index increases of 3.5 points in patients with kidney flares vs 2 in those without flares (p=0.001). At second, but not at first kidney biopsy, two different models predicted eGFR decrease at multivariate analysis. The first included activity index >3 (OR: 3.230; p=0.013) and chronicity index >4 (OR: 2.905; p=0.010), and the second model included moderate/severe cellular/fibrocellular crescents (OR: 4.207; p=0.010) and interstitial fibrosis (OR: 2.525; p=0.025). At second biopsy, chronicity index increased in 3/4 of participants. Its increase was predicted by kidney dysfunction at presentation and occurrence of LN flares. Kidney function impairment was predicted by both activity and chronicity index and by some of their components at repeated biopsy, but not at first biopsy.
Identifiants
pubmed: 35973744
pii: 9/1/e000721
doi: 10.1136/lupus-2022-000721
pmc: PMC9386217
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Ann Intern Med. 1983 Jul;99(1):1-8
pubmed: 6344715
Lupus. 2013 Dec;22(14):1446-54
pubmed: 24097970
Am J Kidney Dis. 2014 May;63(5):820-34
pubmed: 24485147
Pathol Res Pract. 1989 Aug;185(2):225-30
pubmed: 2678034
Kidney Int. 1994 Feb;45(2):544-50
pubmed: 8164443
Kidney Int. 2018 Oct;94(4):659-661
pubmed: 30243311
Kidney360. 2021 Nov 5;3(1):122-132
pubmed: 35368572
Autoimmun Rev. 2018 Oct;17(10):1022-1027
pubmed: 30107267
Am J Kidney Dis. 1999 Sep;34(3):530-9
pubmed: 10469865
J Autoimmun. 2016 Nov;74:27-40
pubmed: 27349351
J Rheumatol. 2009 Oct;36(10):2218-23
pubmed: 19648307
Ann Rheum Dis. 2010 Jan;69(1):61-4
pubmed: 19155235
Kidney Int. 2020 Jan;97(1):156-162
pubmed: 31685314
Am J Med. 1983 Sep;75(3):382-91
pubmed: 6351607
Clin J Am Soc Nephrol. 2014 Feb;9(2):279-84
pubmed: 24262502
Lupus. 2018 Aug;27(9):1455-1463
pubmed: 29759047
Nephrol Dial Transplant. 2012 Apr;27(4):1472-8
pubmed: 21931127
Lupus Sci Med. 2014 Apr 01;1(1):e000004
pubmed: 25396056
Ann Rheum Dis. 2020 Jun;79(6):713-723
pubmed: 32220834
Lupus. 2005;14(4):265-72
pubmed: 15864912
Arthritis Care Res (Hoboken). 2011 Jun;63(6):865-74
pubmed: 21309006
Ann Rheum Dis. 2018 Sep;77(9):1318-1325
pubmed: 29730634
Lupus Sci Med. 2014 Aug 06;1(1):e000018
pubmed: 25379188
Lancet. 1992 Sep 26;340(8822):741-5
pubmed: 1356175
Clin J Am Soc Nephrol. 2006 Sep;1(5):925-32
pubmed: 17699309
Lupus Sci Med. 2020 Feb 18;7(1):e000389
pubmed: 32153796
Nephrol Dial Transplant. 2017 Aug 01;32(8):1338-1344
pubmed: 26250434
Kidney Int. 1996 Dec;50(6):2047-53
pubmed: 8943489
Semin Arthritis Rheum. 1993 Oct;23(2):135-48
pubmed: 8266110
Kidney Int. 1984 Apr;25(4):689-95
pubmed: 6482173
Am J Nephrol. 2020;51(6):483-492
pubmed: 32320985
Kidney Int. 2018 Apr;93(4):789-796
pubmed: 29459092
Arthritis Rheum. 2007 Mar;56(3):924-37
pubmed: 17328070
Lupus. 2005;14(11):890-5
pubmed: 16335581
Nephrol Dial Transplant. 2007 Sep;22(9):2531-9
pubmed: 17510096
Kidney Int. 2001 Jan;59(1):304-16
pubmed: 11135084
Kidney Int. 2004 Feb;65(2):521-30
pubmed: 14717922